Literature DB >> 27706947

Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.

Jen-Yu Cheng1, Eng-Yen Huang1,2, Shun-Neng Hsu1, Chong-Jong Wang1,3.   

Abstract

OBJECTIVE: To compare the dose distributions of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) using the simultaneous integrated boost (SIB) technique with that of the traditional midline block (MB) technique for boosting the parametrium in patients with cervical cancer.
METHODS: Treatment plans using VMAT or IMRT with the SIB technique (VMAT-SIB and IMRT-SIB) and IMRT followed by the MB technique (IMRT-MB) were generated for each of the 10 patients with cervical cancer. For the SIB plans, 45-Gy and 50-Gy dose levels in 25 equal fractions were set for the pelvis planning target volume 45 (PTV45) and the parametrial boost volume (PTV50), respectively. For the IMRT-MB plans, the parametrium was sequentially boosted with the MB technique (5.4 Gy in three fractions) after pelvic IMRT (PTV45).
RESULTS: Volume receiving 100% of the prescribed dose or more coverage of the PTV50 was significantly better for VMAT-SIB and IMRT-SIB than that for IMRT-MB (99.08 and 99.31% compared with 91.79%, respectively; p < 0.05). VMAT-SIB and IMRT-SIB both generated significantly greater doses to the organs at risk (OARs) except for the volume receiving 50 Gy or more doses, which were significantly lower for the bladder and bowel. Comparable results were achieved with VMAT-SIB and IMRT-SIB.
CONCLUSION: The VMAT-SIB and IMRT-SIB techniques are promising in terms of dose distributions and tumour coverage, although these approaches might result in slightly higher doses of radiation to the OARs. Advances in knowledge: This is the first study to examine the feasibility of the SIB technique using IMRT or VMAT to boost the parametrium. The techniques dosimetrically produced better target coverage but resulted in slightly higher doses to the OARs.

Entities:  

Mesh:

Year:  2016        PMID: 27706947      PMCID: PMC5604918          DOI: 10.1259/bjr.20160526

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  35 in total

1.  Counterpoint: Time to retire the parametrial boost.

Authors:  Jacob Christian Lindegaard; Kari Tanderup
Journal:  Brachytherapy       Date:  2012 Mar-Apr       Impact factor: 2.362

2.  The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.

Authors:  Johannes C A Dimopoulos; Christian Kirisits; Primoz Petric; Petra Georg; Stefan Lang; Daniel Berger; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-12       Impact factor: 7.038

3.  The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.

Authors:  Christian Kirisits; Stefan Lang; Johannes Dimopoulos; Daniel Berger; Dietmar Georg; Richard Pötter
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-01       Impact factor: 7.038

4.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer.

Authors:  Karen Lim; William Small; Lorraine Portelance; Carien Creutzberg; Ina M Jürgenliemk-Schulz; Arno Mundt; Loren K Mell; Nina Mayr; Akila Viswanathan; Anuja Jhingran; Beth Erickson; Jennifer De los Santos; David Gaffney; Catheryn Yashar; Sushil Beriwal; Aaron Wolfson; Alexandra Taylor; Walter Bosch; Issam El Naqa; Anthony Fyles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

5.  Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.

Authors:  Christel N Nomden; Astrid A C de Leeuw; Marinus A Moerland; Judith M Roesink; Robbert J H A Tersteeg; Ina Maria Jürgenliemk-Schulz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-12       Impact factor: 7.038

6.  Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.

Authors:  Claire Charra-Brunaud; Valentin Harter; Martine Delannes; Christine Haie-Meder; Philippe Quetin; Christine Kerr; Bernard Castelain; Laurence Thomas; Didier Peiffert
Journal:  Radiother Oncol       Date:  2012-05-25       Impact factor: 6.280

7.  Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.

Authors:  Mark W McDonald; Karen D Godette; Daisy J Whitaker; Lawrence W Davis; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-21       Impact factor: 7.038

8.  MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.

Authors:  Jacob Christian Lindegaard; Lars Ulrik Fokdal; Søren Kynde Nielsen; Jens Juul-Christensen; Kari Tanderup
Journal:  Acta Oncol       Date:  2013-08-21       Impact factor: 4.089

Review 9.  Literature review with PGI guidelines for delineation of clinical target volume for intact carcinoma cervix.

Authors:  Anshuma Bansal; Firuza D Patel; Bhavana Rai; Abhishek Gulia; Bhaswanth Dhanireddy; S C Sharma
Journal:  J Cancer Res Ther       Date:  2013 Oct-Dec       Impact factor: 1.805

10.  Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.

Authors:  C A Perez; P W Grigsby; H Castro-Vita; M A Lockett
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-07-30       Impact factor: 7.038

View more
  4 in total

1.  Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.

Authors:  Ryuta Hirai; Tomoaki Tamaki; Mitsunobu Igari; Y U Kumazaki; Shin-Ei Noda; Shingo Kato
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  Pelvic side wall recurrence in locally advanced cervical carcinoma treated with definitive chemoradiation-clinical impact of pelvic wall dose.

Authors:  Aparna Gangopadhyay; Subrata Saha
Journal:  Br J Radiol       Date:  2019-07-25       Impact factor: 3.039

3.  Changing the Prognosis of Metastatic Cervix Uteri Adenosquamous Carcinoma through a Multimodal Approach: A Case Report.

Authors:  Mihai Teodor Georgescu; Dragos Eugen Georgescu; Teodor Florin Georgescu; Luiza Georgia Serbanescu
Journal:  Case Rep Oncol       Date:  2020-12-23

4.  A model to guide the management and decision of re-planning during radiotherapy for cervical cancer.

Authors:  Wei Zhang; Xiuhua Li; Tingting Lin; Fang Ma; Xiaoyu Ma; Xiaoli Wu; Yingming Sun; Xiaoge Sun
Journal:  Transl Cancer Res       Date:  2021-12       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.